16/03/2026
🎉 Research Achievement at Blackpool Teaching Hospitals NHS Foundation Trust!
We’re proud to announce that Blackpool Teaching Hospitals has successfully enrolled its first participant into the INTACT‑2 study — an important national trial exploring new ways to support recovery for patients who develop anaemia following critical or intensive care treatment.
INTACT‑2 (INtravenous Iron and eryThropoietin to treat Anaemia following CriTical care‑2) is a multi‑centre, randomised, double‑blind, placebo‑controlled clinical trial investigating whether a combination of IV iron and erythropoietin can help improve oxygen‑carrying capacity, reduce fatigue, and support a faster, stronger recovery for people leaving Critical Care.
This is a fantastic milestone for our Critical Care and our Research team, demonstrating our continued commitment to offering patients access to cutting‑edge studies that aim to improve outcomes during some of the most challenging periods of their health journey.
A huge well done to everyone involved — from screening to consent to delivery. Your teamwork ensures our patients benefit from world‑class research right here in Blackpool.